Javascript must be enabled to continue!
Severe recurrent hypoglycaemia following discontinuation of olanzapine
View through CrossRef
Severe hypoglycaemia is a diagnostic challenge.1 It is often explained by mismatch between insulin doses, food ingestion and exercise. Recurrent hypoglycaemia can indicate underlying medical problems. Drug related events usually concern insulin or sulphonylureas. However, withdrawal of drugs which can cause insulin resistance can be causative if insulin or sulphonylureas continue.2We report the case of an insulin-treated patient who presented with severe recurrent hypoglycaemia. After exclusion of secondary causes of hypoglycaemia it was established that at the time of diagnosis of diabetes he had been taking olanzapine. This had subsequently been discontinued. Olanzapine is recognised to cause diabetes and diabetic ketoacidosis. Our patient was able to discontinue insulin therapy.
Title: Severe recurrent hypoglycaemia following discontinuation of olanzapine
Description:
Severe hypoglycaemia is a diagnostic challenge.
1 It is often explained by mismatch between insulin doses, food ingestion and exercise.
Recurrent hypoglycaemia can indicate underlying medical problems.
Drug related events usually concern insulin or sulphonylureas.
However, withdrawal of drugs which can cause insulin resistance can be causative if insulin or sulphonylureas continue.
2We report the case of an insulin-treated patient who presented with severe recurrent hypoglycaemia.
After exclusion of secondary causes of hypoglycaemia it was established that at the time of diagnosis of diabetes he had been taking olanzapine.
This had subsequently been discontinued.
Olanzapine is recognised to cause diabetes and diabetic ketoacidosis.
Our patient was able to discontinue insulin therapy.
Related Results
Sirolimus therapy in a child with partially diazoxide-responsive hyperinsulinaemic hypoglycaemia
Sirolimus therapy in a child with partially diazoxide-responsive hyperinsulinaemic hypoglycaemia
Summary
Hyperinsulinaemic hypoglycaemia (HH), which causes persistent neonatal hypoglycaemia, can result in neurological damage and it’s management is challenging. Diazoxide is the...
Protective Role of Vitamin C and Silymarin Against Olanzapine-Induced Hepatotoxicity in Albino Rats: A Histopathological and Biochemical Study
Protective Role of Vitamin C and Silymarin Against Olanzapine-Induced Hepatotoxicity in Albino Rats: A Histopathological and Biochemical Study
Background:
Olanzapine is an atypical antipsychotic drug for treating bipolar disorders and Schizophrenia. Regardless of being used as a common antipsychotic
drug, there are report...
Frequency of Hypoglycaemia after Different Bariatric Surgical Procedures
Frequency of Hypoglycaemia after Different Bariatric Surgical Procedures
<b><i>Objectives:</i></b> The frequency of postprandial hypoglycaemia after different operative procedures of bariatric surgery (BS) is unknown, although th...
Olanzapine/Samidorphan: New Drug Approved for Treating Bipolar I Disorder and Schizophrenia
Olanzapine/Samidorphan: New Drug Approved for Treating Bipolar I Disorder and Schizophrenia
Objective To describe the approval of olanzapine/samidorphan, compare the clinical trial data, and summarize key findings, with a focus on impact to clinical practice. Data Sources...
Olanzapine, not resperidone, exacerbates β-cell function and mass in ovariectomized diabetic rats and estrogen replacement reverses them
Olanzapine, not resperidone, exacerbates β-cell function and mass in ovariectomized diabetic rats and estrogen replacement reverses them
The effect of risperidone and olanzapine on β-cell function and mass was investigated in 90% pancreatectomized and ovariectomized female rats, of which some were treated with estro...
Non-medical use of olanzapine by people on methadone treatment
Non-medical use of olanzapine by people on methadone treatment
Aims and methodWe examined non-medical use (NMU) of olanzapine among adults on methadone treatment. Information was collected on patient demographics and NMU of olanzapine. The Alc...
Roli i olanzapinës në modulimin e homeostazës kockore – hulumtim eksperimental paraklinik
Roli i olanzapinës në modulimin e homeostazës kockore – hulumtim eksperimental paraklinik
Long-term use of olanzapine may adversely affect oral health by disrupting bone homeostasis and increasing the risk of alveolar resorption and structural bone damage. This preclini...
Adverse events in intensively treated children and adolescents with type 1 diabetes
Adverse events in intensively treated children and adolescents with type 1 diabetes
The main objective of this study was to examine the relation between adverse events and degree of metabolic control and multiple‐dose treatment. A total of 139 children, aged betwe...

